iCAD acquired by RadNet in all-stock merger; shares to be delisted from Nasdaq

ICAD INC

Merger completed July 17, 2025; each iCAD share converted into 0.0677 RadNet common shares.
iCAD CEO Dana Brown received $200K retention bonus; CFO Eric Lonnqvist received $62.5K.
All iCAD directors and officers replaced; Howard Berger named CEO, Mark Stolper CFO.
iCAD common stock to be delisted from Nasdaq effective July 18, 2025; Form 25 to be filed.
iCAD's AI breast health platform in 50+ countries, 1,500+ provider sites, targeting 10M annual mammograms.

item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.